The table below shows Barinthus Biotherapeutics plc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$0.00
$14.97M
$802.00K
$44.70M
$268.00K
$4.82M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$25.56M
$42.24M
$44.87M
$42.35M
$20.37M
$14.39M
SG&A
$40.83M
BRNS annual revenue (10-K history)
Barinthus Biotherapeutics plc. reported annual revenue of $0.00 for fiscal year 2025. That is down 100.0% from $14.97M in fiscal 2024. Over the 6 fiscal years shown, annual revenue declined from $4.82M (FY 2020) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.